MedPath

POstopeRative Standardization of Care: THe Implementation of Best Practice After Pancreatic Resection

Not Applicable
Conditions
Pancreatic Diseases
Pancreatitis
Pancreatic Neoplasms
Pancreatic Cancer
Interventions
Other: Best practice algorithm for postoperative care
Registration Number
NCT03400280
Lead Sponsor
St. Antonius Hospital
Brief Summary

This Nationwide stepped-wedge cluster randomized trial is designed to evaluate if the implementation of a best practice algorithm for postoperative care results in a decrease in incidence of major complications and death after pancreatic resection as compared to current practice.

Detailed Description

Rationale

Pancreatic resection is a major abdominal operation with 50% chance of postoperative complications. A feared complication is severe pancreatic fistula, in which there is leakage of enzyme rich fluid into the abdominal cavity. Adequate complication management appears to be the most important factor in improving outcomes of patients undergoing pancreatic resection.

Objective

To investigate whether implementation of a best practice algorithm for postoperative care focusing on early detection and step-up management of postoperative pancreatic fistula results in a lower rate of major complications and death after pancreatic resection as compared to current practice

Study design

A nationwide stepped-wedge, cluster randomized, superiority trial. In this design all participating centers cross over from current practice to best practice according to the algorithm, but are randomized to determine the exact order. At the end of the trial, all centers will have implemented the best practice algorithm.

Study population

All centers performing pancreatic surgery in the Netherlands (i.e. the Dutch Pancreatic Cancer Group).

Intervention

Cluster level education on postoperative care according to a best practice algorithm, focusing on early detection and step-up management of postoperative pancreatic fistula. This algorithm is based on findings in Dutch observational cohort studies, systematic literature analyses, an inventory in current protocols on postoperative care and expert opinion. The proposed algorithm is validated in a multicenter cohort and consensus upon this algorithm is reached with pancreatic surgeons from all centers of the Dutch Pancreatic Cancer Group. The final algorithm was reviewed critically by the advisory committee of internationally respected experts in the field of pancreatology before implementation in this trial.

Comparison

Postoperative care according to current practice.

Endpoints

The primary outcome was measured in all patients undergoing pancreatic resection and is a composite of major complications (i.e. postpancreatectomy bleeding, new-onset organ failure and death). Secondary endpoints include the individual components of the primary endpoint and other clinical outcomes, number of patients receiving adjuvant chemotherapy, healthcare resource utilization and costs analysis. Follow-up will be 90 days after pancreatic resection.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1600
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Best practiceBest practice algorithm for postoperative carePostoperative care according to a best practice algorithm for postoperative care focussing on early detection and minimally invasive management of postoperative pancreatic fistula.
Primary Outcome Measures
NameTimeMethod
Composite primary endpoint90 days after index pancreatic resection

The primary endpoint of this trial is a composite of the most severe complications associated to postoperative pancreatic fistula. This endpoint will be considered positive if one of the following complications occurs within 90 days after pancreatic resection: late postpancreatectomy bleeding, new-onset organ failure and/or death

Secondary Outcome Measures
NameTimeMethod
Late postpancreatectomy bleeding90 days after index pancreatic resection

Defined in accordance to the International Study Group on Pancreatic Surgery (ISGPS) definition as bleeding occurring any time after 24 hours after pancreatic resection.

Cost-effectiveness90 days after index pancreatic resection

Calculated by comparing health effects and medical costs related to both strategies up to 90 days after pancreatic resection.

Success of implementation90 days after index pancreatic resection

Measured as number of patients in whom the algorithm was not followed and timing of abdominal CT scans in both strategies.

Postoperative mortality90 days after index pancreatic resection

Measured as rate of death at 90-day follow-up

New-onset organ failure90 days after index pancreatic resection

Measured as organ failure occuring any time within 90 days after resection, not present at time of index pancreatic resection.

Postoperative morbidity90 days after index pancreatic resection

Including complications according to the Clavien-Dindo system and pancreatectomy specific complications according to the ISGPS definitions (e.g. postpancreatectomy bleeding, postoperative pancreatic fistula, postoperative bile leak, postoperative chyle leak and delayed gastric emptying).

Adjuvant chemotherapy90 days after index pancreatic resection

Measured as number of patients receiving adjuvant chemotherapy at 90-day follow-up

Trial Locations

Locations (17)

Reinier de Graaf gasthuis

🇳🇱

Delft, Netherlands

Tjongerschans

🇳🇱

Heerenveen, Netherlands

Jeroen Bosch Ziekenhuis

🇳🇱

's Hertogenbosch, Netherlands

VUmc

🇳🇱

Amsterdam, Netherlands

Academic Medical Center

🇳🇱

Amsterdam, Netherlands

RAKU (St. Antonius ziekenhuis & UMC Utrecht)

🇳🇱

Utrecht, Netherlands

Onze Lieve Vrouwen Gasthuis

🇳🇱

Amsterdam, Netherlands

Amphia ziekenhuis

🇳🇱

Breda, Netherlands

UMCG

🇳🇱

Groningen, Netherlands

LUMC

🇳🇱

Leiden, Netherlands

Isala klinieken

🇳🇱

Zwolle, Netherlands

Catharina ziekenhuis

🇳🇱

Eindhoven, Netherlands

Medisch Spectrum Twente

🇳🇱

Enschede, Netherlands

Radboud UMC

🇳🇱

Nijmegen, Netherlands

Erasmus MC

🇳🇱

Rotterdam, Netherlands

Maastricht UMC

🇳🇱

Maastricht, Netherlands

Maasstad ziekenhuis

🇳🇱

Rotterdam, Netherlands

© Copyright 2025. All Rights Reserved by MedPath